Interview with Hans-Dieter Hausner, Senior Bayer Representative, Bayer Australia
Many MNCs are having pipeline concerns in the “new era” of post-blockbuster drug development. How is…
Bayer Australia
Last updated: 01.06.2015
Address: 875 Pacific Highway, Pymble NSW 2073,Australia
Tel: +61 (0) 2 9391 6000
Web: http://www.bayer.com.au/scripts/pages/en/index.php
Company description
Bayer Australia is part of an international, research-based group with major businesses in health care, nutrition and high-tech materials.
Employing over 108,000 people worldwide, and 840 in Australia/New Zealand, the Bayer Group has a portfolio of over 5,000 products and operations in nearly all countries of the globe. Worldwide operations are managed from Group headquarters in Leverkusen, Germany.
Bayer Australia aims for technological leadership in its core activities. Fundamental to business is the acknowledgment that technical and commercial expertise involves a responsibility to work for the common good and contribute to sustainable development.
In 2008 the Bayer Group recorded sales of EUR 32.9 billion, and invested heavily in research and development. Bayer’s operations in Australia and New Zealand generated AU$728 million ($NZ868 million) in revenue in 2008.
Products and services
Antibiotic, Cardiovascular, Hormone replacement therapy, Oncology
Interviews
Related
Australia / Opportunities for the Life Science Industry post-COVID
Regular PharmaBoardroom contributor Brendan Shaw outlines how his home country of Australia has so far successfully…
Australia / Growing Clinical Trials Even in Pandemic’s Wake
In an exclusive new podcast, DIA Global Forum Australia/New Zealand Regional Editor Richard Day (University of…
Opinion / The Powerful Impact of Taking a Patient-Centric Approach in an Evolving Health Landscape
Janssen Australia & New Zealand’s Bruce Goodwin argues that greater adoption of patient-centric practices…
Interview with Mal Eutick, CEO, Phebra Australia
Can you start by giving our readers a brief overview of the company’s history here and your most notable…
Interview with Marisa Petersen, Managing Director, George Clinical, Australia
Would you begin by outlining the role & importance of George Clinical within the George Institute, highlighting…
Interview with Vlado Perkovich, Executive Director, The George Institute,…
Would you begin by giving an introduction to our international readers of the institute, highlighting recent…
Interview with John Chalmers, Senior Director, The George Institute
For those that are not familiar with your name, would you start by introducing yourself? After obtaining my PhD in…
Interview with Megan Fookes, Director, Rare Voices
Rare Voices Australia is a new organisation that has been established after the national rare diseases symposium in…
Australia: Where Value Beats Cost
In some ways the Australian medicines industry is going through the same restructuring and challenges as the…
Interview with Craig Moore, Director, Hahn Healthcare
Can you outline the significance of the current PBS to the industry and in particular the impact it has on service…
Interview with Radek Sali, CEO, SWISSE
Speaking to the Australian environment, how would you rate the market in terms of companies like Swisse? After…
Interview with Albert Spanos, General Manager, Celgene Australia
In our interviews we have been hearing two opinions on the success of PBS reforms: that it works as it should in…
